NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
    32.
    发明申请
    NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS 有权
    非核苷酸逆转录酶抑制剂

    公开(公告)号:US20110245296A1

    公开(公告)日:2011-10-06

    申请号:US13073631

    申请日:2011-03-28

    摘要: Heteroaromatic compounds of Formula I: are HIV reverse transcriptase inhibitors, wherein R1, R2, R3, R4 and R5 are defined herein. The compounds of Formula I and their pharmaceutically acceptable salts are useful in the inhibition of HIV reverse transcriptase, the prophylaxis and treatment of infection by HIV and in the prophylaxis, delay in the onset or progression, and treatment of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.

    摘要翻译: 式I的杂芳族化合物是HIV逆转录酶抑制剂,其中R1,R2,R3,R4和R5如本文所定义。 式I化合物及其药学上可接受的盐可用于抑制HIV逆转录酶,预防和治疗HIV感染以及预防,延缓发作或进展以及AIDS治疗。 化合物及其盐可以用作药物组合物中的成分,任选与其它抗病毒剂,免疫调节剂,抗生素或疫苗组合使用。

    Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
    33.
    发明授权
    Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase 失效
    氮杂环戊烷衍生物作为硬脂酰辅酶抑制剂,δ-9去饱和酶

    公开(公告)号:US07754745B2

    公开(公告)日:2010-07-13

    申请号:US12227549

    申请日:2007-06-08

    摘要: Azacyclopentane derivatives of structural formula (I) are selective inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD1) relative to other known stearoyl-coenzyme A desaturases. The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease; atherosclerosis; obesity; diabetes; neurological disease; metabolic syndrome; insulin resistance; liver steatosis; and non-alcoholic steatohepatitis.

    摘要翻译: 结构式(I)的氮杂环戊烷衍生物是相对于其它已知的硬脂酰辅酶A去饱和酶的硬脂酰辅酶Aδ-9去饱和酶(SCD1)的选择性抑制剂。 本发明的化合物可用于预防和治疗与脂质合成和代谢异常有关的病症,包括心血管疾病; 动脉粥样硬化 肥胖; 糖尿病; 神经系统疾病; 代谢综合征; 胰岛素抵抗; 肝脂肪变性 和非酒精性脂肪性肝炎。

    Azacyclopentane Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase
    36.
    发明申请
    Azacyclopentane Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase 失效
    氮杂环戊烷衍生物作为硬脂酰辅酶A-9去饱和酶的抑制剂

    公开(公告)号:US20090093527A1

    公开(公告)日:2009-04-09

    申请号:US12227549

    申请日:2007-06-08

    摘要: Azacyclopentane derivatives of structural formula (I) are selective inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD1) relative to other known stearoyl-coenzyme A desaturases. The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease; atherosclerosis; obesity; diabetes; neurological disease; metabolic syndrome; insulin resistance; liver steatosis; and non-alcoholic steatohepatitis.

    摘要翻译: 结构式(I)的氮杂环戊烷衍生物是相对于其它已知的硬脂酰辅酶A去饱和酶的硬脂酰辅酶Aδ-9去饱和酶(SCD1)的选择性抑制剂。 本发明的化合物可用于预防和治疗与脂质合成和代谢异常有关的病症,包括心血管疾病; 动脉粥样硬化 肥胖; 糖尿病; 神经系统疾病; 代谢综合征; 胰岛素抵抗; 肝脂肪变性 和非酒精性脂肪性肝炎。